Wolverine Stack
Muscle/RecoveryRegenerative blendExperimental
Common shop blend of BPC-157 plus TB-500. Not a single API. Both components are unapproved and WADA-relevant (BPC-157 is S0; TB-500/Tฮฒ4 is prohibited-class).
For research use only.
Key Facts
- CAS
- โ
- Molecular Weight (MW)
- โ
- Half-life
- โ
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- Vendor-dependent
- Last updated
- 8/23/2026
- Targets
- Angiogenic / actin pathways (component-dependent)
Overview
Common shop blend of BPC-157 plus TB-500. Not a single API. Both components are unapproved and WADA-relevant (BPC-157 is S0; TB-500/Tฮฒ4 is prohibited-class).
Protocol
- Dosage Range
- See component entries (BPC-157, TB-500) โ blend ratios vary by vendor
- Frequency
- Vendor-dependent
- Cycle
- โ
- Administration Route
- Subcutaneous
- Reconstitution Guide
- โ
Science
Mechanism of Action
Intended combination of gastric pentadecapeptide repair signaling and thymosin-ฮฒ4-fragment actin/migration biology. No registration trial of the blend.
Targets
Angiogenic / actin pathways (component-dependent)
Studies
- BPC-157 reviewโ Journal/year not available
Benefits
Convenience listing for a widely sold stack
Potential Side Effects
- Injection reactions
- Component-specific unknowns
References
- PMID 21030672External link ยท Year โ
- WADA Prohibited List 2026External link ยท Year โ